Table 2.

Research into the use of (R)-ketamine beyond depression, according to [67].

Condition	References
Cognitive impairments	[16,34,75,76,77,78,79,80,81,82,83,84,85,86]
COVID-19	[87,88,89,90,91,92,93]
Inflammatory disease	[36,37,78,91,94,95,96,97,98]
Ischemic stroke	[99,100,101,102,103]
Multiple sclerosis	[48,92]
Organophosphate poisoning	[104,105,106,107,108]
Osteoporosis	[109,110,111,112,113]
Parkinson’s disease	[114,115,116,117,118]
Perioperative anesthesia	[13,96,119,120,121,122,123,124,125,126]
Substance use disorder	[127,128,129]